世界最先端の研究で医学の発展に寄与

2017年

2017年 業績・論文

Ueno N,  Nishimura N,  Ueno S,  Endo S,  Tatetsu H,  Hirata S,  Hata H,  Matsuoka M,  Mitsuya H,  Okuno Y.

PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.

Oncogene. In press. 2017.

 

Nishimura N,  Endo S,  Ueno S,  Ueno N,  Tatetsu H,  Hirata S,  Hata H,  Komohara Y, Takeya M, Mitsuya H, Okuno Y.

A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivo.

Biochem Biophys Res Commun. In press. 2017.

 

Kinosada H, Yasunaga JI, Shimura K, Miyazato P, Onishi C, Iyoda T, Inaba K, Matsuoka M.

HTLV-1 bZIP factor enhances T-cell proliferation by impeding the suppressive signaling of co-inhibitory receptors.

PLoS Pathog.13: e1006120 2017.

お気軽にお問い合わせください TEL 096-373-5156 受付時間 9:00 - 18:00 [ 土・日・祝日除く ]

  • Facebook
  • Hatena
  • twitter
  • Google+
PAGETOP